- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
本帖最后由 StephenW 于 2011-4-6 19:27 编辑
limi2011321 发表于 2011-4-6 19:05
谢谢您的鼓励!我也相信,现在的科技这样发达,神五、神六、神七都载人上天了,小小的丙肝病毒不会肆虐多久 ...
两个新的药物,已经出售,但价格昂贵.
New hepatitis C drugs from Merck &Co. and Johnson & Johnson (JNJ) are being sold in France for 22,000euros ($31,271) and more, a precedent some doctors say may limitaccess after the medicines are approved throughout Europe.
J&J and Vertex Pharmaceuticals Inc. (VRTX)’s telaprevir costs22,000 euros under a French program for seriously ill patientsfor whom there is no other effective treatment on the market,according to patient association SOS Hepatites. Merck & Co. saidits boceprevir costs 30,000 euros under the same program.
The price may drop once the drugs are approved for thebroader market, Merck and J&J executives said. Still, the Frenchmodel shows the new drugs may triple the cost of hepatitis Ctreatment, leaving England, Russia and eastern Europe likely todelay use or restrict which patients are allowed access, saidAntonio Craxi, director of gastroenterology and internalmedicine at the University of Palermo.
|
|